author-photo

Xiang-Meng Li

Academy of Medical Sciences, United Kingdom

4

Papers

9

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Predictive and prognostic potential of TP53 in patients with advanced non-small cell cancer treated with EGFR-TKI: Analysis of a phase III randomized clinical trial (CTONG 0901)

2020 Clinical Lung Cancer
Show All
- Source
- Cite
- Save
Citations (6)
Association of allele frequency of EGFR mutation with efficacy of EGFR TKIs in advanced non-small cell lung cancer.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
The continued osimertinib plus chemotherapy overcoming resistance after histologic transformation in EGFR-mutant lung adenocarcinoma treated with osimertinib.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Clinical outcomes of NSCLC patients with acquired RET rearrangement after resistance to osimertinib.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)